1. Development of diagnostic kits for cancers.

2. Serve research institutes and provide multiple cell lines from ATCC sources.

3. Provide various drug-resistant cells, Luc-expressing cell lines, and other service projects for scientific research.

       Cancer precision therapy through living cell sensitivity testing

     Currently, precision medicine for cancer treatment is the main treatment method, and it is based on gene mutations through gene sequencing. However, gene mutations sometimes could not accurately predict the efficacy of specific cancer drugs. To overcome this problem, we start with pathological tissue, isolate pathological cells, and then screen and validate various potential targeted drugs to provide precise support for rational drug use in cancer patients.


Product Services